165 related articles for article (PubMed ID: 7325046)
1. Multiple sclerosis: an overview.
Rose AS
Adv Neurol; 1981; 31():3-9. PubMed ID: 7325046
[No Abstract] [Full Text] [Related]
2. [Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].
Tourtellotte WW
Rev Neurol (Paris); 1972 Nov; 127(5):497-504. PubMed ID: 4588993
[No Abstract] [Full Text] [Related]
3. Membranes, myelin, and the pathophysiology of multiple sclerosis.
Waxman SG
N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271
[No Abstract] [Full Text] [Related]
4. [Presentation of selected studies on the disease picture of multiple sclerosis].
Schmidt RM; Neumann V; Kissig B; Kuppe G; Ludewig R
Nervenarzt; 1987 Jul; 58(7):403-12. PubMed ID: 3498125
[No Abstract] [Full Text] [Related]
5. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
[TBL] [Abstract][Full Text] [Related]
6. [Study of cellular immunity in multiple sclerosis].
Caputo D; Zibetti A; Manara F; Bisaccia G
Minerva Med; 1977 Feb; 68(6):413-6. PubMed ID: 300150
[No Abstract] [Full Text] [Related]
7. New treatments for multiple sclerosis.
Hallpike JF
Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
[No Abstract] [Full Text] [Related]
8. Scientific overview of multiple sclerosis.
Walker JE
Prog Clin Biol Res; 1982; 106():233-7. PubMed ID: 6757942
[No Abstract] [Full Text] [Related]
9. The pathogenesis and basis for treatment in multiple sclerosis.
Compston A
Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: current concepts and management.
Arnason BG
Hosp Pract (Off Ed); 1982 Feb; 17(2):81-9. PubMed ID: 6210614
[No Abstract] [Full Text] [Related]
11. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
Hommes OR
Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
[No Abstract] [Full Text] [Related]
12. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
Wolswijk G; Balesar R
Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
[TBL] [Abstract][Full Text] [Related]
13. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.
Gay FW
Clin Neurol Neurosurg; 2006 Mar; 108(3):234-40. PubMed ID: 16364541
[TBL] [Abstract][Full Text] [Related]
14. [Regenerative capacity in multiple sclerosis].
Lubetzki C
Bull Acad Natl Med; 2008 Mar; 192(3):495-504; discussion 505-6. PubMed ID: 18819695
[TBL] [Abstract][Full Text] [Related]
15. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
Tourbah A; Fontaine B; Lyon-Caen O
Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
[TBL] [Abstract][Full Text] [Related]
16. Symposium on etiology, diagnosis and treatment of multiple sclerosis. Recent concepts of etiology: implications for treatment.
Silberberg DH
Mod Treat; 1970 Sep; 7(5):879-89. PubMed ID: 4933353
[No Abstract] [Full Text] [Related]
17. Approaches to the development of pharmacological interventions in multiple sclerosis.
Davis FA; Schauf CL
Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674
[No Abstract] [Full Text] [Related]
18. [Auto-immunity and multiple sclerosis].
Goudemand M
Lille Med; 1973 Nov; 18(9):1149-57. PubMed ID: 4603354
[No Abstract] [Full Text] [Related]
19. [The severity of disease and intensity of the immune response in multiple sclerosis].
Schädlich HJ; Felgenhauer K; Schifferdecker M
Nervenarzt; 1984 Aug; 55(8):441-3. PubMed ID: 6483066
[No Abstract] [Full Text] [Related]
20. Medical grand rounds. Multiple sclerosis.
J Tenn Med Assoc; 1984 Feb; 77(2):92-7. PubMed ID: 6727338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
